A novel therapeutic showed significant promise in slowing aortic valve calcification, potentially extending time until or eliminating need for transcatheter or surgical intervention for stenosis, ...
7d
MORE than 5,000 Brits have missed out on lifesaving cancer checks thanks to an NHS mishap. Health chiefs have since rushed out letters to every person affected, apologising for the failure, ...
Abdominal aortic aneurysm (AAA) is a severe aortic disease for which no pharmacological interventions have yet been developed. This investigation focused on identifying protein‐based therapeutic ...
Aortic valve stenosis (AVS) is a significant health concern affecting over 1.5 million Americans and millions more globally. Researchers at Mayo Clinic are exploring the use of a new drug called ...
Aortic valve stenosis (AVS) is a significant health concern affecting over 1.5 million Americans and millions more globally. Researchers at Mayo Clinic are exploring the use of a new drug called ...
New drug may reduce need for aortic valve surgeries by slowing disease progression Date: February 24, 2025 Source: Mayo Clinic Summary: Aortic valve stenosis (AVS) is a significant health concern ...
Chronic inflammation is involved in the development of abdominal aortic aneurysm (AAA). A tertiary lymphoid structure (TLS) within vascular lesions has recently been focused on for its role in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback